Since my last coverage , shares of Clover Health Investments, Corp. ( CLOV ) are down 34% as a result of disappointing Q3 earnings that saw a major spike in medical costs, leading the company to slash itsAs a former managing editor at a financial media publication focused on mid and small caps, I am using my experience to present investment opportunities in undervalued companies. My experience, combined with my academic background in financial markets and institutions, allows me to bring thorough research a ...

Core Insights - Clover Health Investments, Corp. (CLOV) shares have decreased by 34% following disappointing Q3 earnings, primarily due to a significant increase in medical costs, prompting the company to reduce its guidance [1] Financial Performance - The Q3 earnings report revealed a major spike in medical costs for Clover Health, which has negatively impacted its financial outlook [1] Market Trends - The decline in CLOV shares reflects broader market reactions to disappointing earnings reports, particularly in the healthcare sector where rising costs are a concern [1]

Core Viewpoint - Investors are currently concerned about the healthcare industry, particularly health insurers like UnitedHealth Group, which have seen significant stock declines due to rising claims and medical costs. However, Oscar Health is positioned to return to profitability by 2026 despite current challenges [1][2]. Company Overview - Oscar Health is an emerging health insurer targeting the individual paying market, which has faced rising costs but is expected to benefit from long-term trends in the healthcare sector [2][4]. - The company has grown its customer base from 200,000 in 2019 to 2.1 million in the last year, leveraging a technology-driven approach to enhance customer experience [10]. Financial Performance - Oscar Health reported a quarterly operating loss of approximately $129 million due to increased medical loss ratios stemming from higher service usage [5]. - The company plans to increase health insurance plan prices by 28% in 2026 to address losses and aims to maintain $12 billion in premium revenue despite potential customer declines [8][12]. Market Dynamics - The expiration of COVID-19 related healthcare subsidies is expected to reduce the number of individuals purchasing insurance, impacting Oscar Health's customer base in the short term [6][7]. - Despite these challenges, the overall shift from employer-based to individual payers in the health insurance market presents a long-term growth opportunity for Oscar Health [9]. Investment Potential - Current market conditions suggest that investors are overly pessimistic about Oscar Health's future profitability, with a potential price-to-earnings ratio below 8 if the company achieves a 5% net income margin [11][13].

MOH DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Molina Healthcare, Inc. Investors to Secure Counsel Before Important December 2 Deadline in Securities Class Action - MOHNovember 29, 2025 10:21 PM EST | Source: The Rosen Law Firm PANew York, New York--(Newsfile Corp. - November 29, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Molina Healthcare, Inc. (NYSE: MOH) between February 5, 2025 and July 23, 2025, both dates inclusive (t ...

Millions of Americans who buy health insurance through the Affordable Care Act marketplace will face staggering premium increases in 2026 if enhanced subsidies expire on Dec. 31. Although Congress discussed extending the subsidies during the recent government shutdown, negotiations have hit a wall, leaving millions in limbo. The return of the so-called “subsidy cliff” means anyone earning an income that exceeds 400% of the federal poverty level — $62,600 for individuals or $128,600 for a family of four — ...

Core Viewpoint - Centene (CNC) is currently undervalued despite recent struggles, with potential upside linked to possible extensions of ACA insurance subsidies, which could positively impact its business model [1][4]. Company Overview - Centene is based in St. Louis and manages government-sponsored health insurance programs, including Medicaid, Medicare, and ACA plans [2]. - The current market capitalization of Centene is $19 billion, with a stock price of $39.32 [3]. Recent Performance - Centene's stock price has seen significant volatility, dropping from over $56 per share in July to below $26 in early August due to concerns over subsidy extensions and Medicaid cuts [5][6]. - The stock has rebounded nearly 19% over the past month, aided by better-than-expected earnings and revenue reports [7]. Market Influences - The stock's performance is closely tied to Medicare and Medicaid spending, as well as the status of ACA health plans [8]. - Recent reports suggest that President Trump may propose a two-year extension for ACA insurance subsidies, which could garner Republican support and benefit Centene as the largest provider in ACA marketplaces [4].

NEW YORK, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Spirit Aviation Holdings, Inc. (OTCMKTS:FLYYQ) and Molina Healthcare, Inc. (NYSE: MOH). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided. Spirit Aviation Holdings, Inc. (OTCMKTS:FLYY ...

Key Takeaways CVS Health's MBR fell to 92.8% in Q3 2025 as prior PDR effects and gov business gains lifted results.CVS' improvement stemmed from nonrecurring PDR, favorable prior period development and better gov performance.CVS expects about 91% full-year 2025 MBR, keeping a prudent view of medical cost trends through year-end.CVS Health’s (CVS) Health Care Benefits segment recorded a medical benefit ratio (MBR) of 92.8% in the third quarter of 2025 compared with 95.2% in the prior year. The metric shows t ...

Headquartered in Woonsocket, Rhode Island, CVS Health Corporation (CVS) is a healthcare platform that spans retail pharmacies, pharmacy benefits management through CVS Caremark, specialty pharmacy services, and walk-in care clinics via MinuteClinic. The company also delivers health insurance through Aetna and supports seniors through Oak Street Health. “Large-cap” companies, typically valued above $10 billion, tend to anchor investor expectations through scale and stability. CVS Health firmly fits the cat ...

Ah, the stock market. A bastion of rational expectation, meticulous forecasting, and, occasionally, the wild, unpredictable pronouncements of a certain former (and potentially future) President. Donald J. Trump, a man whose approach to policy often resembles a game of economic roulette, continues to keep investors, analysts, and anyone with a passing interest in their retirement fund on their toes. Forget the “Art of the Deal”; we’re living through the “Art of the Market Mayhem,” where a single Truth Social ...